Reaction
Blood Chromogranin A Increased reporting signals
As of the last recalculation, Blood Chromogranin A Increased appears in 450 FAERS reports alongside 11 co-occurring drug terms. The strongest observed disproportionality signal is OCTREOTIDE ACETATE (PRR 439.9).
Important: FAERS is a spontaneous, voluntary, unverified reporting system. PRR and ROR identify reporting patterns for investigation; they are not incidence rates and do not establish causation.
| Drug | Co-reports | PRR | ROR |
|---|---|---|---|
| Octreotide Acetate | 177 | 439.9 | 442.5 |
| Lanreotide Acetate | 26 | 162.7 | 163.3 |
| Everolimus | 67 | 71.4 | 71.5 |
| Everolimus Tablets | 20 | 57.7 | 57.8 |
| Bicalutamide | 11 | 34.2 | 34.2 |
| Lutetium Lu 177 Vipivotide Tetraxetan | 9 | 32.2 | 32.2 |
| Abiraterone | 9 | 31.2 | 31.2 |
| Dutasteride | 4 | 22.9 | 23.0 |
| Temozolomide | 9 | 20.1 | 20.1 |
| Cabozantinib | 12 | 11.8 | 11.8 |
| Abiraterone Acetate | 9 | 10.3 | 10.3 |